By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TM3 Therapeutics 



Leiden      Netherlands
Phone: n/a Fax: n/a


SEARCH JOBS

TM3 Therapeutics is focused on novel treatments for neurodegenerative and metabolic diseases by developing unique metabolite replacement therapies. Our goal is to improve survival outcomes and quality of life of patients with rare, genetic neurological diseases that have limited or no treatment options. Our clinical development program specifically targets the coenzyme A biosynthetic pathway, whose malfunction leads to impaired quality of life, progressive loss of function and significantly reduced life expectancy. Our vision is to work together with key opinion leaders, researchers and clinicians to expedite the development of new therapeutics to treat diseases with significant unmet medical need. Based in Leiden, The Netherlands, the company was founded in 2017.

YEAR FOUNDED:

2017

LEADERSHIP:

CEO: Enej Kuscer


Key Statistics


Email:
Ownership: Private

Web Site: TM3 Therapeutics
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->